Deerfield, IL, February 9, 2017 –Takeda Pharmaceuticals U.S.A., Inc. today welcomed the recently-elected mayor of Baltimore and nationally-known political leader to its Chicagoland office. Mayor Cynthia Pugh spoke to an audience of Deerfield-based Takeda employees. Hundreds of employees were invited to learn about issues of concern in the African-American community as part of the company’s effort to help educate its own employees on diversity and inclusion topics impacting many communities in the U.S.
“We’re delighted to host Mayor Pugh during our celebration of Black History Month as an esteemed source of insight dedicated to promoting economic opportunity for African-Americans,” said Laurene Giagnorio, senior vice president, human resources and administration, Takeda Pharmaceuticals U.S.A., Inc. “Our continued commitment to our inclusive culture is a high priority and key to our success. Takeda’s award-winning workplace supports attraction and retention of the finest talent, determined to find innovative solutions for the patients we serve.”
Takeda has been recognized, Giagnorio explains, for its diversity and inclusion efforts. Since starting its program several years ago, Takeda has expanded its policies and programs to be even more inclusive. The company has established six employee resource groups (ERGs) which help validate company policies and programs to strengthen recruiting and retention efforts. The ERG focused on African-American employees is sponsoring Takeda’s Black History Month activities and invited Mayor Pugh given her prominent role as a leader in the African-American community.
Mayor Pugh was elected the 50th mayor of Baltimore in December, 2016. She has a long history of public service, serving in state and local government roles. In addition to her service in government, Mayor Pugh has been active in the Baltimore business community, working as a business owner, television and radio news reporter, banker, business developer and dean of a local business college, among other accomplishments. She also is an author of a series of children’s books encouraging exercise and healthy eating.
Further, she has been recognized for her leadership and commitment to diversity and inclusion by numerous local and national organizations, including the United States Small Business Advocate of the Year, the National Association of Securities Professionals Joyce Johnson Award, and the African Methodist Episcopal Church’s Living Legacy Award.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology, central nervous system and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.
For more information, visit http://www.takeda.com/news
About Takeda in the U.S.
Takeda Pharmaceuticals U.S.A., Inc. is the U.S. commercial organization of Takeda Pharmaceutical Company Limited. Takeda has a strong commitment to the U.S. with more than 5,000 employees, a significant R&D presence, Oncology and Vaccine headquarters and manufacturing capabilities.